Internationally known clinical and translational researcher also co-leads the GI oncology team

国际知名的临床和转化研究人员也共同领导胃肠道肿瘤学团队

DETROIT, May 20, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team (MDT). Dr. Saif is a world-renowned hematologist and oncologist specializing in GI cancers, experimental therapeutics and pharmacogenetics.

底特律，2024年5月20日/PRNewswire/--芭芭拉·安·卡马诺斯癌症研究所欢迎Wasif Saif，M.D.，MBBS担任第一阶段临床试验多学科团队的新任领导者以及胃肠道（GI）和神经内分泌肿瘤学多学科团队（MDT）的共同领导者。赛义夫博士是世界著名的血液学家和肿瘤学家，专门研究胃肠道癌症，实验疗法和药物遗传学。

He joined Karmanos on March 1, 2024..

他于2024年3月1日加入卡马诺斯。。

'Karmanos Cancer Institute is a trailblazer in cancer research and has been a major contributor to significant strides in new drug and therapy development,' said Dr. Saif. 'I am most excited about continuing translational research at this NCI-Designated Comprehensive Cancer Center with access to a diverse cancer population.

赛义夫博士说：“卡马诺斯癌症研究所是癌症研究的开拓者，是新药和治疗开发取得重大进展的主要贡献者。”我最兴奋的是在这个NCI指定的综合癌症中心继续进行转化研究，可以接触到多种癌症人群。

This cancer center's rich data from clinical trials, studies, and investigations largely shapes the understanding of cancer and treatment for multiple populations. The avenues the physicians, scientists, and researchers have open to them are endless, and I am honored to be part of this significant work in Detroit.'.

该癌症中心来自临床试验，研究和调查的丰富数据在很大程度上影响了对多种人群癌症和治疗的理解。医生、科学家和研究人员为他们开辟的道路是无尽的，我很荣幸能在底特律参与这项重要的工作。”。

Dr. Saif has an extensive background in translational research and developing and managing clinical trials. As the Phase 1 Clinical Trials MDT leader, he will lead a team of physician co-investigators, non-physician providers, clinical personnel, and Clinical Trials Office staff to oversee Phase 1 solid tumor investigations.

Saif博士在转化研究以及开发和管理临床试验方面拥有广泛的背景。作为第一阶段临床试验MDT的领导者，他将领导一个由医师联合研究人员、非医师提供者、临床人员和临床试验办公室工作人员组成的团队，监督第一阶段实体瘤的研究。

Karmanos' Phase 1 team oversees over 70 clinical trials at various stages of the protocol lifecycle. Members of this MDT include medical oncologists specializing in many different cancers, who research, study, and develop therapies, bringing them from lab to bedside. Having a Phase 1 team in Detroit gives cancer patients access to promising new treatments not offered elsewhere..

Karmanos的第一阶段团队在方案生命周期的各个阶段监督70多项临床试验。MDT的成员包括专门研究许多不同癌症的医学肿瘤学家，他们研究，研究和开发治疗方法，将他们从实验室带到床边。在底特律拥有一个1期团队，可以让癌症患者获得其他地方没有的有前途的新疗法。。

Dr. Saif will also work alongside Najeeb Al Hallak, M.D., MS, medical oncologist, in leading the GI and Neuroendocrine Oncology MDT, a team made up of cardiothoracic surgeons, endocrinologists, gastroenterologists, hematologists, medical oncologists, pathologists, radiologists, radiation oncologists, and surgical oncologists that dedicate their research and treatment to GI and neuroendocrine cancers.

赛义夫博士还将与医学肿瘤学家纳吉布·哈拉克（Najeebal-Hallak）一起领导胃肠道和神经内分泌肿瘤学MDT，该团队由心胸外科医生、内分泌学家、胃肠病学家、血液学家、医学肿瘤学家、病理学家、放射科医生、放射肿瘤学家和外科肿瘤学家组成，致力于胃肠道和神经内分泌癌症的研究和治疗。

He specializes in treating anal, biliary, colon, carcinoid, esophagus, GIST, liver, pancreas, rectum, and stomach cancers. His research interests include anticancer drug development with an emphasis on analysis of pharmacokinetics and pharmacodynamics, biomarker discovery, pharmacogenetics, epidemiology and disparity studies in GI cancers, and developing complementary and alternative medicines to treat cancer..

他擅长治疗肛门癌、胆道癌、结肠癌、类癌、食道癌、胃肠道间质瘤、肝癌、胰腺癌、直肠癌和胃癌。他的研究兴趣包括抗癌药物开发，重点是药代动力学和药效学分析，生物标志物发现，药物遗传学，流行病学和胃肠道癌症差异研究，以及开发治疗癌症的补充和替代药物。。

'Dr. Saif's philosophy and leadership in novel therapeutics fits our vision of continuing to grow our Phase 1 Clinical Trials Program at Karmanos. His research interests in GI cancers will complement our GI team. I am confident we will see more breakthrough discoveries from these MDTs with Dr. Saif's leadership and vision,' said Boris Pasche, M.D.

'博士。赛义夫在新型疗法方面的理念和领导力符合我们在卡马诺斯继续发展第一阶段临床试验计划的愿景。他对胃肠道癌症的研究兴趣将补充我们的胃肠道团队。医学博士鲍里斯·帕什（BorisPasche）说，我相信，在赛义夫博士的领导和远见下，我们将从这些MDT中看到更多突破性发现。

Ph.D., FACP, president and CEO at Karmanos..

博士、FACP、Karmanos总裁兼首席执行官。。

In addition to his leadership roles, Dr. Saif sees patients at Karmanos Cancer Center in Detroit. He is also a professor in the Department of Oncology at Wayne State University School of Medicine.

除了领导角色外，赛义夫博士还在底特律的卡马诺斯癌症中心看病。他还是韦恩州立大学医学院肿瘤学系的教授。

Before joining Karmanos, Dr. Saif served on the faculty at the University of Alabama at Birmingham, Yale University School of Medicine in New Haven, Connecticut, Columbia University in New York City, and Tufts University School of Medicine in Boston, Massachusetts. He has served as the leader of the GI oncology division at Yale, Columbia, and Tufts and as the program leader in experimental therapeutics at Tufts.

在加入卡马诺斯之前，赛义夫博士曾供职于阿拉巴马大学伯明翰分校、康涅狄格州纽黑文耶鲁大学医学院、纽约哥伦比亚大学和马萨诸塞州波士顿塔夫茨大学医学院。他曾担任耶鲁大学、哥伦比亚大学和塔夫茨大学胃肠肿瘤科的负责人，以及塔夫茨大学实验治疗学的项目负责人。

He has also served in executive roles at Northwell Health in New Hyde Park, New York and Orlando Health. Dr. Saif is a member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society of Medical Oncology (ESMO), Carcinoid Foundation, and American Society of Pharmacology and Experimental Therapeutics (ASPET).

他还曾在纽约新海德公园的Northwell Health和奥兰多Health担任高管。Saif博士是美国临床肿瘤学会（ASCO），美国癌症研究协会（AACR），欧洲医学肿瘤学会（ESMO），类癌基金会和美国药理学和实验治疗学会（ASPET）的成员。

He has served as the principal investigator on over 75 clinical trials and has published over 650 scientific papers in addition to textbook chapters, abstracts, and proceedings of meetings..

他曾担任75多项临床试验的首席研究员，除教科书章节、摘要和会议记录外，还发表了650多篇科学论文。。

Dr. Saif earned his medical degree from King Edward Medical College in Lahore, Pakistan, and completed his internal medicine residency at the University of Connecticut School of Medicine in Farmington, Connecticut. He completed medical oncology and hematology fellowships at the National Cancer Institute, National Heart, Lung and Blood Institute, National Institutes of Health, and National Naval Medical Center in Bethesda, Maryland..

赛义夫博士在巴基斯坦拉合尔的爱德华国王医学院获得医学学位，并在康涅狄格州法明顿的康涅狄格大学医学院完成了内科住院医师的工作。他在马里兰州贝塞斯达的国家癌症研究所、国家心肺血液研究所、国家卫生研究院和国家海军医学中心获得了医学肿瘤学和血液学研究金。。

View Dr. Saif's physician profile here. To learn more about Phase 1 Clinical Trials or to request an appointment, visit karmanos.org or call 1-800-KARMANOS.

在此处查看Saif博士的医生档案。要了解更多关于第一阶段临床试验的信息或要求预约，请访问karmanos.org或致电1-800-karmanos。

About the Barbara Ann Karmanos Cancer Institute

关于芭芭拉·安·卡马诺斯癌症研究所

Karmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit.

卡马诺斯癌症研究所是通过勇气、承诺和同情心进行变革性癌症护理、研究和教育的领导者。卡马诺斯的愿景是一个没有癌症的世界。作为迈凯轮医疗保健的一部分，卡马诺斯是密歇根州最大的癌症护理和研究提供者。75多年来，行政和研究总部以及首屈一指的专科癌症医院一直位于底特律市中心。

With 16 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship.

Karmanos拥有16个网络站点，在密歇根州和俄亥俄州北部提供世界知名的护理和临床试验。国家癌症研究所认定卡马诺斯是全国最好的癌症中心之一，拥有综合癌症中心称号。它与韦恩州立大学医学院（WayneStateUniversity School of Medicine）的学术合作为癌症研究和教育提供了框架——定义新的护理标准并提高生存率。

For more information, call 1-800-KARMANOS (800-527-6266) or visit www.karmanos.org. Follow Karmanos on Facebook, Twitter, LinkedIn and YouTube..

有关更多信息，请致电1-800-KARMANOS（800-527-6266）或访问www.KARMANOS.org。在Facebook、Twitter、LinkedIn和YouTube上关注KARMANOS。。

View original content to download multimedia:https://www.prnewswire.com/news-releases/karmanos-welcomes-wasif-saif-md-to-lead-phase-1-clinical-trials-302149747.html

查看原始内容以下载多媒体：https://www.prnewswire.com/news-releases/karmanos-welcomes-wasif-saif-md-to-lead-phase-1-clinical-trials-302149747.html

SOURCE Karmanos Cancer Institute

来源：Karmanos癌症研究所